Seres Therapeutics Announces First Patient Enrolled in Phase 1b Study of SER-155, an Investigational Microbiome Therapeutic to Reduce the Risk of…

SER-155 is designed to reduce the incidence of infection, mortality and GvHD in adults undergoing hematopoietic stem cell transplantation (HSCT) Seres is collaborating with Memorial Sloan Kettering Cancer Center and The University of Chicago for the study CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seres Therapeutics (Nasdaq: MCRB), a leading microbiome therapeutics company, announced today that the first patient has been enrolled in the SER-155 Phase 1b study. SER-155 is an investigational, oral, cultivated microbiome therapeutic.

Read more
AVROBIO Presents Clinician Experience with FAB-GT Clinical Trial and Updated Safety Data for Investigational Gene Therapies in Fabry Disease and…

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a vision to free people from a lifetime of genetic disease, today hosted a panel of investigators managing the patient experience in the Phase 2 FAB-GT clinical trial of AVR-RD-01, an investigational one-time gene therapy for Fabry disease, at the 14th International Congress of Inborn Errors of Metabolism (ICIEM), Nov.

Read more
Mitigating Toxicities Will Position BCMA for Role in Triple-Class Refractory Multiple Myeloma – OncLive

In a recent OncLive Peer Exchange program, an expert panel of oncologic hematologists discussed the latest developments and future of BCMA in multiple myeloma. Defining pharmacologic treatment strategies for patients with multiple myeloma whose disease becomes refractory to standard-of-care treatment options presents a challenge for investigators

Read more
Human Primary Cells Market 2021 | Know the Latest COVID19 Impact Analysis and Strategies of Key Players: Lonza, Thermo Fisher Scientific,…

The Latest Released Human Primary Cells market study has evaluated the future growth potential of Global Human Primary Cells market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities and restraints in Human Primary Cells market

Read more
Researcher Works for Diversity, Inclusion in Sciences, One Journal at a Time – Lab Manager Magazine

KINGSTON, RI A University of Rhode Island (URI) researcher and colleagues who study invasive species have published a series of articles in the journal Biological Invasions aimed at identifying and addressing concerns about diversity, equity, and inclusion in the journal, which they believe will lead to a better understanding of invasive species around the world. Laura Meyerson, URI professor of natural resources science and deputy editor-in-chief of Biological Invasions,led a survey of the journals editorial board, authors and reviewers to define who we are and where were located, she said

Read more
Raw Marijuana Won’t Get You Stoned, But It Does Have Some Interesting Benefits – Benzinga – Benzinga

This article was originally published on The Fresh Toast and appears here with permission. Amateur cannabis users likely dont know the inner workings of cannabis. They dont know that a key element for the high experience is heat, which transforms the compound THCA into THC, which is why someone might try to add raw marijuana into their sweets and expect some sort of benefit

Read more